Toronto, Ontario–(Newsfile Corp. – July 15, 2021) – The Hash Corporation (CSE: REZN) (“Hashco” or the “Company“), a company focusing on the production of hashish and other premium cannabis products using the adaption of old-world traditions, is pleased to announce that it has appointed Todd Shapiro, Chief Executive Officer and Director of Red Light Holland Corp. (“Red Light Holland“) to its Advisory Board.
Todd Shapiro has over 20 years of experience as a marketing entrepreneur and brand ambassador having serviced many well established brands including Canopy Growth and Boveda Inc in the Cannabis Industry. As the head of Red Light Holland, Mr. Shapiro, while focusing on building Red Light Holland’s brand has developed a global network of contacts in the regulated substance industry, along with a deep understanding of emerging markets, distribution and incredible social media exposure, all of which Hashco hopes to leverage as it positions itself for expansion into the hash and cannabis concentrate market in Canada.
“We are extremely pleased to have Todd join our Advisory Board. He is a visionary with a vast network of connections, and the business acumen necessary to assist Hashco in developing new business opportunities,” said Chris Savoie, the Chief Executive Officer and Director of Hashco.
Todd Shapiro is excited to join the team at Hashco and said the following, “We’ve all heard of hash, but have we all heard of Hashco? I look forward to advising the hard-working team on how to expand their brand name and work within a delicate framework to get as much exposure and distribution as possible.”
Todd Shapiro and the Company entered into an advisory board agreement pursuant to which the Company has granted Todd Shapiro an aggregate of 1,000,000 RSUs which will vest quarterly over the first year from the date of issuance. Each vested RSU entitles the holder to receive one common share in the capital of Hashco.
About The Hash Corporation
HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.
As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.
For additional information on the Company:
Chris Savoie
Chief Executive Officer and Director
Tel: 1-833-420-7396
Email: chris@hashco.ca
Forward-Looking Statements
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Not for distribution to United States newswire services or for dissemination in the United States.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/90298
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…